Carlisle Companies Inc

More

• Big drugmakers think small with nanomedicine deals Friday, 3 May 2013 | 6:03 AM ET

  *Pfizer, Amgen, AstraZeneca among firms placing bets. LONDON, May 3- Is nanomedicine the next big thing? Three deals struck this year by privately held Bind Therapeutics, together worth nearly $1 billion if experiments are successful, highlight a new interest in using such tiny carriers to deliver drug payloads to specific locations in the body.

• Apple's Roller-Coaster Ride to Set Market Tone Tuesday, 23 Apr 2013 | 8:38 PM ET

  

  Apple briefly got some of its shine back, after it delivered a package of capital programs that shareholders have been clamoring for.

• Bringing Jobs Back to the US  Tuesday, 27 Nov 2012 | 2:06 PM ET

  

  Discussing business in Charlotte, the fiscal cliff and onshoring, with David Roberts, Carlisle Companies CEO.